COSMO Pharmaceuticals SA (0RGI) — Defensive Interval Ratio
COSMO Pharmaceuticals SA (0RGI) has a Defensive Interval Ratio of 171 days as of June 2025. Defensive assets of £22.80 Million (cash £-, short-term investments £1.18 Million, receivables £21.62 Million) cover 171 days of daily cash needs of £133.48K/day. See COSMO Pharmaceuticals SA working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
COSMO Pharmaceuticals SA Defensive Interval Ratio (2004–2024)
This chart shows how COSMO Pharmaceuticals SA's Defensive Interval Ratio has evolved across 20 annual periods from 2004 to 2024. As of June 2025, the ratio stands at 171 days, meaning defensive assets of £22.80 Million can fund 171 days of operations without new revenue. See debt-free asset ratio of COSMO Pharmaceuticals SA to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for COSMO Pharmaceuticals SA (2004–2024)
The table below presents the year-by-year Defensive Interval Ratio for COSMO Pharmaceuticals SA from 2004 to 2024, covering 20 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see COSMO Pharmaceuticals SA stock valuation.
| Year | DIR (days) | Defensive Assets (GBP) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 889 days | £117.61 Million | £132.24K/day | £- | £98.67 Million | ▲ +485 days |
| 2023 | 404 days | £28.45 Million | £70.45K/day | £- | £- | ▲ +228 days |
| 2022 | 176 days | £93.74 Million | £534.10K/day | £- | £55.13 Million | ▼ -651 days |
| 2021 | 827 days | £48.10 Million | £58.18K/day | £- | £23.65 Million | ▼ -76 days |
| 2020 | 903 days | £53.91 Million | £59.71K/day | £- | £26.91 Million | ▼ -3208 days |
| 2019 | 4111 days | £176.90 Million | £43.03K/day | £- | £157.82 Million | ▲ +507 days |
| 2018 | 3604 days | £151.51 Million | £42.04K/day | £- | £138.75 Million | ▲ +2835 days |
| 2017 | 769 days | £40.95 Million | £53.24K/day | £- | £27.76 Million | ▼ -475 days |
| 2016 | 1244 days | £63.80 Million | £51.28K/day | £- | £48.84 Million | ▲ +342 days |
| 2015 | 902 days | £61.87 Million | £68.61K/day | £- | £45.06 Million | ▲ +720 days |
| 2014 | 181 days | £30.12 Million | £166.18K/day | £- | £25.33 Million | ▼ -4841 days |
| 2013 | 5022 days | £133.44 Million | £26.57K/day | £- | £121.82 Million | ▲ +4837 days |
| 2012 | 184 days | £6.25 Million | £33.92K/day | £- | £1.00 | ▼ -234 days |
| 2011 | 419 days | £11.83 Million | £28.24K/day | £- | £- | ▲ +254 days |
| 2010 | 165 days | £12.30 Million | £74.55K/day | £- | £101.00K | ▼ -344 days |
| 2009 | 509 days | £10.16 Million | £19.97K/day | £- | £139.00K | ▲ +486 days |
| 2008 | 22 days | £578.00K | £25.71K/day | £- | £- | ▲ +34 days |
| 2006 | -12 days | £-370.00K | £31.67K/day | £- | £- | ▼ -201 days |
| 2005 | 189 days | £6.30 Million | £33.28K/day | £- | £- | ▲ +56 days |
| 2004 | 133 days | £2.83 Million | £21.23K/day | £- | £- | — |